MSC2499550A

DRUG2 trials

Sponsors

Merck KGaA, Darmstadt, Germany, Merck Pty Ltd

Conditions

HealthySchistosoma haematobium, urogenital schistosomiasis or bilharzia

Phase 1

Relative Bioavailability Trial of L-Praziquantel in Healthy Volunteers

CompletedNCT02271984

Merck KGaA, Darmstadt, GermanyHealthy

Start: 2014-10-31End: 2014-12-31Updated: 2018-01-03

Phase 3

Active, not recruitingPACTR202001553028239

Merck Pty LtdSchistosoma haematobium, urogenital schistosomiasis or bilharzia

Start: 2020-05-06Target: 110Updated: 2026-08-03